By working backwards from NF-κB in the pathway, we can examine which (if any) of the major NF-κB-activating cell-surface receptors and/or intracellular regulators may be changed in schizophrenia to add further support cytoplasmic release of NF-κB. Here, NFKB1 is linked to schizophrenia.